Amgen Completes Surprise AcquisitionApril 2012 | Corporate Financing Analysis
CFW View: Of the companies we expected to purchase Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals), Amgen was the bottom of our list. In terms of synergies and similarities between the two companies, they are as different as is possible. However, this transaction makes a lot more sense when considering Amgen's slow and strategic shift from being a leading global biotech company to a global Big Pharma firm.
To read the full article, please choose one of the following options: